Rheumatic Heart Disease - stuck in Prosthetic Valve
Abstract
Full Text:
PDFReferences
http://burmachildren.com/who-we- are/conditions-we- treat/cardiac-disease/
https://www.nhlbi.nih.gov/health/health-topics/topics/hvd/trials
Global Atlas on Cardiovascular Disease Prevention and Control. Mendis S, Puska P, Norrving B editors.
World Health Organization (in collaboration with the World Heart Federation and World Stroke Organization),
Geneva 2011.
http://emedicine.medscape.com/article/1962779-overview#a2.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724245/)
Horstkotte D, Burckardt D. Prosthetic valve thrombosis. J Heart Valve Dis.1995;4:141–53.
Laplace G, Lafitte S, Labe`que JN, et al. Clinical significance of early thrombosis after prosthetic mitral valve
replacement. J Am Coll Cardiol 2004;43:1283–90.
Deviri E, Sareli P, Wisenbaugh T, et al. Obstruction of mechanical heart valve prostheses: clinical aspect and
surgical management. J Am Coll Cardiol 1991;17:646–50.
Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve
replacement. J Am Coll Cardiol 1995;25:1111–9.
Cribier A, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for
the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698
–703.
. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S,
Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation.
;113: 842–850.
Grube E, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the
second- and current thirdgeneration self-expanding CoreValve prosthesis: device success and 30-day clinical
outcome. J Am Coll Cardiol. 2007;50:69 –76.
Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, Webb JG. Transapical
transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114:591–596.
Walther T, et all. Transapical minimally invasive aortic valve implantation: multicenter
experience. Circulation. 2007;116(suppl):I-240–I- 245.
Philippe Pibarot,Jean G. Prosthetic Heart Valves Selection of the Optimal Prosthesis and Long-Term
Management .Circulation. 2009;119:1034-1048.
Montorsi P, Cavoretto D, Repossini A, et al. Valve design characteristics and cine-fluoroscopic appearance
of five currently available bileafiet prosthetic heart valves. Am J Cardiac Imag 1996;10:29–41.
Iung B, Cormier B, Dadez E, et al. Small abnormal echoes after mitral valve
replacement with bileaflet mechanical prostheses: predisposing factors and effect
on thromboembolism. J Heart Valve Dis 1993;2:259–66
Barbetseas J, Nagueh SF, Pitsavos C, et al. Differentiating thrombus from Pannus formation in obstructed
mechanical prosthetic valves: an evaluation of clinical transthoracic and TEE parameters. J Am Coll Cardiol
;32:1410–7
https://www.cryolife.com/products/on-x- heart-valves/heart- valve-design- features/
Rajesh Rajan, Velayudhan Nair Vasantha Krishnakumar, Charantharayil Gopalan Bahuleyan ,Padmanabhan
Balachandran Nair.Mitral Prosthetic Valve Obstruction and Its Complications.Int Cardiovasc Res
J.2015;9(4):247-250.
Hsiao-Ching Cheng, Pei-Luen Kang1, and Shoa-Lin Lin.Management of Mechanical Heart Valve
Obstruction. J Intern Med Taiwan 2008; 19: 379-386
Arun prasath Palamalai,1 Sujal Nikhil Ramakrishnan,1 Anand Kumar gopi.Safety and Efficacy of
Thrombolysis for Stuck Valve in Rheumatic Heart Disease - A Single Centre Experience . India journal of the
American college of cardiology , 2015;65:1 7.
https://watermark.silverchair.com
. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and
prevention. Ann Thorac Surg. 2005; 79:1072–1080.
DOI: https://doi.org/10.37628/ijcn.v3i1.654
Refbacks
- There are currently no refbacks.